1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Enrolled patients and tumor characteristics
No. % Total 30 100 Site Oral cavity 1 3.3 Oropharynx 17 56.7 Hypopharynx-larynx 12 40 Stage III 6 20 IVA 20 66.7 IVB 4 13.3 TNM T1N3M0 1 3.3 T1N2M0 1 3.3 T2N1M0 3 10 T2N2M0 11 36.7 T3N0M0 3 10 T3N2M0 3 10 T4N0M0 2 6.7 T4N1M0 3 10 T4N2M0 2 6.7 T4N3M0 1 3.3